Pnc Financial Services Group, Inc. Repligen Corp Transaction History

Pnc Financial Services Group, Inc.

  • $190 Billion
  • Q1 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 3,632 shares of RGEN stock, worth $439,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,632
Previous 3,480 4.37%
Holding current value
$439,508
Previous $500,000 7.6%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$127.24 - $174.24 $19,340 - $26,484
152 Added 4.37%
3,632 $462,000
Q4 2024

Feb 07, 2025
SELL
$123.41 - $160.92 $32,333 - $42,161
-262 Reduced 7.0%
3,480 $500,000
Q3 2024

Nov 08, 2024
SELL
$119.79 - $167.35 $60,853 - $85,013
-508 Reduced 11.95%
3,742 $556,000
Q2 2024

Aug 09, 2024
SELL
$120.0 - $182.95 $62,640 - $95,499
-522 Reduced 10.94%
4,250 $535,000
Q1 2024

May 10, 2024
BUY
$170.78 - $208.42 $35,693 - $43,559
209 Added 4.58%
4,772 $877,000
Q4 2023

Feb 09, 2024
SELL
$114.17 - $185.35 $69,986 - $113,619
-613 Reduced 11.84%
4,563 $820,000
Q3 2023

Nov 13, 2023
SELL
$138.78 - $176.51 $20,817 - $26,476
-150 Reduced 2.82%
5,176 $823,000
Q2 2023

Aug 11, 2023
SELL
$138.42 - $180.31 $138,143 - $179,949
-998 Reduced 15.78%
5,326 $753,000
Q1 2023

May 15, 2023
BUY
$154.26 - $198.1 $617 - $792
4 Added 0.06%
6,324 $1.06 Million
Q4 2022

Feb 10, 2023
SELL
$162.42 - $220.56 $46,289 - $62,859
-285 Reduced 4.31%
6,320 $1.07 Million
Q3 2022

Nov 10, 2022
SELL
$160.42 - $256.21 $33,527 - $53,547
-209 Reduced 3.07%
6,605 $1.24 Million
Q2 2022

Aug 12, 2022
BUY
$140.68 - $188.02 $153,481 - $205,129
1,091 Added 19.06%
6,814 $1.11 Million
Q1 2022

May 12, 2022
BUY
$161.19 - $257.96 $53,676 - $85,900
333 Added 6.18%
5,723 $1.08 Million
Q4 2021

Feb 11, 2022
BUY
$247.59 - $304.47 $106,216 - $130,617
429 Added 8.65%
5,390 $1.43 Million
Q3 2021

Nov 05, 2021
SELL
$194.77 - $324.21 $346,885 - $577,418
-1,781 Reduced 26.42%
4,961 $1.43 Million
Q2 2021

Aug 06, 2021
SELL
$165.87 - $220.95 $108,644 - $144,722
-655 Reduced 8.85%
6,742 $1.35 Million
Q1 2021

May 07, 2021
BUY
$180.37 - $226.26 $40,042 - $50,229
222 Added 3.09%
7,397 $1.44 Million
Q4 2020

Feb 12, 2021
SELL
$148.08 - $206.57 $59,232 - $82,628
-400 Reduced 5.28%
7,175 $1.37 Million
Q3 2020

Nov 06, 2020
BUY
$122.51 - $158.27 $52,189 - $67,423
426 Added 5.96%
7,575 $1.12 Million
Q2 2020

Aug 07, 2020
BUY
$94.33 - $140.48 $18,960 - $28,236
201 Added 2.89%
7,149 $883,000
Q1 2020

May 08, 2020
SELL
$84.96 - $109.14 $43,924 - $56,425
-517 Reduced 6.93%
6,948 $670,000
Q4 2019

Feb 07, 2020
SELL
$73.84 - $93.08 $2.31 Million - $2.91 Million
-31,316 Reduced 80.75%
7,465 $690,000
Q3 2019

Nov 08, 2019
SELL
$76.65 - $95.51 $1.24 Million - $1.54 Million
-16,157 Reduced 29.41%
38,781 $2.97 Million
Q2 2019

Aug 09, 2019
SELL
$54.2 - $85.95 $84,877 - $134,597
-1,566 Reduced 2.77%
54,938 $0
Q1 2019

May 10, 2019
SELL
$49.45 - $62.8 $2,423 - $3,077
-49 Reduced 0.09%
56,504 $0
Q4 2018

Feb 08, 2019
SELL
$48.26 - $68.88 $134,741 - $192,312
-2,792 Reduced 4.7%
56,553 $2.98 Million
Q3 2018

Nov 09, 2018
BUY
$46.8 - $58.97 $22,089 - $27,833
472 Added 0.8%
59,345 $0
Q2 2018

Aug 10, 2018
BUY
$35.26 - $47.04 $1,516 - $2,022
43 Added 0.07%
58,873 $0
Q1 2018

May 11, 2018
SELL
$30.92 - $37.27 $35,805 - $43,158
-1,158 Reduced 1.93%
58,830 $0
Q4 2017

Feb 09, 2018
SELL
$32.53 - $38.92 $11,515 - $13,777
-354 Reduced 0.59%
59,988 $0
Q3 2017

Nov 13, 2017
BUY
$36.98 - $46.06 $2.23 Million - $2.78 Million
60,342
60,342 $0

Others Institutions Holding RGEN

# of Institutions
495
Shares Held
57.6M
Call Options Held
75.6K
Put Options Held
521K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.71B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email